Disseminated histoplasmosis after alemtuzumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Disseminated histoplasmosis after alemtuzumab

Published:2023-06-15 Issue:6 Volume:25 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transplant Infectious Dis

Author:

Siegrist Emily A.¹^ORCID,Thomas Cody²,Khawandanah Mohamad³,Sassine Joseph⁴^ORCID

Affiliation:

1. Department of Pharmacy OU Health Oklahoma City Oklahoma USA

2. Department of Pathology University of Oklahoma Health Sciences Center Oklahoma City Oklahoma USA

3. Hematology‐Oncology Section Department of Medicine University of Oklahoma Health Sciences Center and Stephenson Cancer Center Oklahoma City Oklahoma USA

4. Infectious Diseases Section Department of Medicine University of Oklahoma Health Sciences Center Oklahoma City Oklahoma USA

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.14089

Reference10 articles.

1. Levels of expression of CD52 in normal and leukemic B and T cells: Correlation with in vivo therapeutic responses to Campath-1H

2. Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia

3. Alemtuzumab in T-Cell Malignancies

4. Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*

5. Disseminated Histoplasmosis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP